Upgrade to SI Premium - Free Trial

Mizuho Securities Downgrades Amedisys (AMED) Neutral, PT Cut to $55

August 3, 2016 7:06 AM
Mizuho Securities downgraded Amedisys (NASDAQ: AMED) from Buy to Neutral and cut the price target to $55.00 (from $57.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change Downgrades

Next Articles